Tozaro (private company)
See something wrong or missing? Let us know
Offices:Bedford
Business model:B2BB2C (Retail)SAAS
Tozaro (fka MIP Diagnostics Limited and MIP Discovery) is a British biotechnology company that develops synthetic affinity reagents for cell and gene therapy, via it own process for the manufacture of NanoMIPS, which was developed by Sergey Piletsky and Antonio Guerreiro, but they also do manufacture more traditional polymers as well such as bulk MIPs and rationally designed polymers.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 23.65M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Tozaro
| Name | Criteria | |
|---|---|---|
![]() |
NuvoAir
87%
|
|
![]() |
Synapse Medicine
87%
|
|
![]() |
Aignostics
77%
|
|
![]() |
Bigfinite
77%
|
|
![]() |
Citryll
77%
|
|
![]() |
Jutro Medical
77%
|
|
![]() |
Sarcura
77%
|
|
![]() |
Valink Therapeutics
77%
|
|
![]() |
Inato
77%
|
|
![]() |
Causaly
77%
|
|








Belgium
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal